Provided by Tiger Trade Technology Pte. Ltd.

HANXBIO-B

29.220
-0.080-0.27%
Volume:1K
Turnover:28.45K
Market Cap:3.92B
PE:-26.32
High:29.240
Open:28.000
Low:28.000
Close:29.300
52wk High:33.800
52wk Low:13.480
Shares:134.00M
HK Float Shares:134.00M
Volume Ratio:0.08
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.110
ROE:-27.27%
ROA:-12.63%
PB:5.30
PE(LYR):-26.32
PS:45891.52

Loading ...

Hanx Biopharmaceuticals Posts Announcement on Ai-driven Drug Discovery Collaboration

Reuters
·
Jul 07

Hanx Biopharmaceuticals (wuhan) Co - Enters Agreement to Establish Joint Ai-driven Drug Discovery Lab

THOMSON REUTERS
·
Jul 07

Hanx Biopharmaceuticals (wuhan) Co - Collaborates with Hust-cityu Macau Institute Advanced Interdisciplinary Research Centre

THOMSON REUTERS
·
Jul 07

HANXBIO-B Repurchases 29,500 Shares for HK$854,500

Stock News
·
Jul 06

HANXBIO-B repurchases 29,500 H-shares for HKD 0.85 million, treasury stock climbs to 1.79 million shares

Bulletin Express
·
Jul 06

HANXBIO-B Buys Back 48,700 H Shares for HKD 1.40 Million; Treasury Stock Rises to 1.76 Million Shares

Bulletin Express
·
Jul 03

Hanx Biopharmaceuticals Files HKEX Next-day Disclosure Return on Share Repurchase at HKD 28.68 Avg

Reuters
·
Jul 03

Hanx Biopharma Launches AI Drug Development Collaboration With TwinEdge

MT Newswires Live
·
Jul 03

Hanx Biopharmaceuticals (wuhan) and Twinedge Bioscience Initiates Research Collaboration

Reuters
·
Jul 03

HANXBIO collaborates with Switzerland’s TwinEdge Bioscience to deploy AI-powered “Digital Twin” research for core bispecific antibody HX009

Bulletin Express
·
Jul 02

Hanx Biopharmaceuticals Partners with Twinedge Bioscience on Ai-driven HX009 Development

Reuters
·
Jul 02

Hanx Biopharmaceuticals (wuhan) Co - Collaboration Leverages AI for Translational Research on Hx009

THOMSON REUTERS
·
Jul 02

HANXBIO-B repurchases 16,000 H-shares; treasury stock rises to 1.71 million

Bulletin Express
·
Jul 02

HANXBIO-B Executes Share Buyback, Spending HK$456,000

Stock News
·
Jul 02

Hanx Biopharma Files HKEX Next-day Disclosure Return on Share Repurchase at HKD 28.68-$27.96

Reuters
·
Jul 02

HANXBIO-B Allocates HK$1.95 Million for Share Buyback on June 30

Stock News
·
Jun 30

Hanx Biopharmaceuticals Files HKEX Next-day Disclosure Return on Share Repurchase Cancellation

Reuters
·
Jun 30

HANXBIO-B (03378) Allocates HK$1,023,300 for Share Buyback on June 29

Stock News
·
Jun 29

Hanx Biopharma Files HKEX Next-day Disclosure Return on Share Repurchase for Treasury Shares

Reuters
·
Jun 29

HANXBIO-B Repurchases 44,000 H Shares for HK$1.14 Million, Treasury Stock Rises to 1.59 Million Shares

Bulletin Express
·
Jun 26